Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Horowitz

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimensM Markman, P G Rose, E Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Human papillomavirus and disease status following therapy for cervical cancerE R Unger, S D Vernon, R Nisenbaum, et al.
Cancer|December 15, 1995
Cervical cancer survival in a high risk urban populationW W Thoms, E R Unger, P R Johnson, et al.
Sexually Transmitted Infections|January 1, 2000
Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partnersM A Piper, S T Severin, S Z Wiktor, et al.
Sexually Transmitted Infections|January 1, 2000
HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partnersS D Vernon, E R Unger, M A Piper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group studyS O'Reilly, G F Fleming, S D Barker, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimensM Markman, P G Rose, E Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 1998
Human papillomavirus and disease status following therapy for cervical cancerE R Unger, S D Vernon, R Nisenbaum, et al.
Cancer|December 15, 1995
Cervical cancer survival in a high risk urban populationW W Thoms, E R Unger, P R Johnson, et al.
Sexually Transmitted Infections|January 1, 2000
Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partnersM A Piper, S T Severin, S Z Wiktor, et al.
Sexually Transmitted Infections|January 1, 2000
HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partnersS D Vernon, E R Unger, M A Piper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group studyS O'Reilly, G F Fleming, S D Barker, et al.
Pageof 4